Indiva Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Indiva.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 53.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Indiva Limited's (CVE:NDVA) Subdued P/S Might Signal An Opportunity
May 28
Indiva Limited (CVE:NDVA) Stock Catapults 33% Though Its Price And Business Still Lag The Industry
Sep 29Is Indiva (CVE:NDVA) Using Debt In A Risky Way?
Sep 17Is Indiva (CVE:NDVA) A Risky Investment?
Apr 19Is Indiva (CVE:NDVA) Using Too Much Debt?
Feb 26Would Indiva (CVE:NDVA) Be Better Off With Less Debt?
Sep 04Would Indiva (CVE:NDVA) Be Better Off With Less Debt?
Nov 30In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Indiva has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2024 | 37 | -4 | -2 | -1 | N/A |
| 12/31/2023 | 38 | -5 | -1 | 0 | N/A |
| 9/30/2023 | 36 | -7 | 0 | 1 | N/A |
| 6/30/2023 | 34 | -9 | 0 | 1 | N/A |
| 3/31/2023 | 35 | -10 | 1 | 2 | N/A |
| 12/31/2022 | 34 | -11 | 0 | 2 | N/A |
| 9/30/2022 | 34 | -12 | -10 | -9 | N/A |
| 6/30/2022 | 34 | -16 | -12 | -10 | N/A |
| 3/31/2022 | 35 | -15 | -16 | -14 | N/A |
| 12/31/2021 | 32 | -15 | -20 | -18 | N/A |
| 9/30/2021 | 30 | -18 | -9 | -7 | N/A |
| 6/30/2021 | 25 | -15 | -14 | -12 | N/A |
| 3/31/2021 | 19 | -16 | -11 | -9 | N/A |
| 12/31/2020 | 15 | -15 | -9 | -7 | N/A |
| 9/30/2020 | 8 | -11 | -11 | -11 | N/A |
| 6/30/2020 | 5 | -10 | -10 | -7 | N/A |
| 3/31/2020 | 3 | -10 | -13 | -8 | N/A |
| 12/31/2019 | 1 | -11 | -22 | -10 | N/A |
| 9/30/2019 | 1 | -11 | -23 | -9 | N/A |
| 6/30/2019 | 0 | -10 | -23 | -9 | N/A |
| 3/31/2019 | 0 | -10 | -23 | -11 | N/A |
| 12/31/2018 | 0 | -9 | -14 | -10 | N/A |
| 9/30/2018 | N/A | -7 | -10 | -8 | N/A |
| 6/30/2018 | N/A | -6 | -8 | -7 | N/A |
| 3/31/2018 | N/A | -5 | -4 | -3 | N/A |
| 12/31/2017 | N/A | -3 | N/A | -2 | N/A |
| 9/30/2017 | N/A | -2 | N/A | -2 | N/A |
| 6/30/2017 | N/A | -2 | N/A | -1 | N/A |
| 3/31/2017 | N/A | -1 | N/A | -2 | N/A |
| 12/31/2016 | N/A | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NDVA.H's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if NDVA.H's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if NDVA.H's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if NDVA.H's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if NDVA.H's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NDVA.H's Return on Equity is forecast to be high in 3 years time